This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_ENDOMETRIUM_EXALLC for full statistics.
Carcinoma in situ of endometrium
CD2_INSITU_ENDOMETRIUM
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
157 |
4. Check minimum number of eventsNone |
157 |
5. Include endpointsNone |
157 |
6. Filter based on genotype QC (FinnGen only) |
157 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D07
- Name in latin
- Carcinoma in situ endometrii (corporis uteri)
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of endometrium
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of endometrium
- Carcinoma in situ of other and unspecified genital organs
- Carcinoma in situ of other and unspecified genital organs
- In situ neoplasms
- In situ neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 157 | 157 | - |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | - |
| Median age at first event (years) | 62.28 | 62.28 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 140
- Matched controls
- 1399
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D07.0
ICD-10 Finland
Carcinoma in situ: Endometrium
+∞
199.1
139
*
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
75.9
63.4
70
18
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
62.0
63.3
73
24
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
33.0
61.1
86
64
PJA01
NOMESCO Finland
Laparoscopic sentinel node excision
192.0
50.7
50
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
59.8
46.1
53
14
N85.1
ICD-10 Finland
Endometrial adenomatous hyperplasia
79.8
32.9
36
6
N95.0
ICD-10 Finland
Postmenopausal bleeding
9.2
26.8
65
120
ZXC96
NOMESCO Finland
Robot assisted procedure
43.2
23.1
28
8
B01AB10
ATC
tinzaparin; parenteral
10.2
20.5
43
58
LCB25
NOMESCO Finland
Hysteroscopic excision of lesion
11.6
20.2
39
45
N84.0
ICD-10 Finland
Polyp of corpus uteri
8.0
19.6
49
88
N85.0
ICD-10 Finland
Endometrial glandular hyperplasia
27.2
15.6
21
9
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
6.1
11.6
33
67
8380/3-C54.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of corpus uteri
38.5
11.5
14
*
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
22.3
11.4
16
8
JN4BD
NOMESCO Finland
Extensive body CT
5.0
10.8
37
94
B01AB05
ATC
enoxaparin; parenteral
3.4
10.5
70
318
SPAT1312
SPAT
General health counselling
3.2
9.6
72
348
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
39.5
9.2
11
*
LCA06
NOMESCO Finland
Biopsy of endometrium
3.9
9.1
41
134
C54.10
ICD-10 Finland
Malignant tumor of endometrium without histology
53.4
8.8
10
*
SPAT1301
SPAT
No procedures
3.0
8.5
67
327
SPAT1249
SPAT
Treatment-related counselling outside office
2.9
8.3
79
435
LCA13
NOMESCO Finland
Curettage of cervix and body of uterus
4.6
7.7
27
69
ULC02
NOMESCO Finland
Hysteroscopy
5.1
7.6
24
55
SPAT1153
SPAT
Removal of sutures
2.8
7.4
64
326
WF090
NOMESCO Finland
Profylactic radiotherapy
42.2
6.8
8
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.6
6.7
62
324
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
4.7
6.7
22
53
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
4.1
6.7
26
74
-
ICD-10 Finland
NA
10.8
6.7
12
12
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
11.8
6.4
11
10
WF003
NOMESCO Finland
Adjuvant radiotherapy
5.7
6.3
17
33
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.8
6.2
20
47
WX408
NOMESCO Finland
General anesthesy, balanced
0.1
6.2
*
240
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
104
177
15.44
69.21
9.9
6.5
—
—
—
0
0
39
41
12.33
34.78
3.2
4.7
3.8
3.8
mmol/l
0.10
39
35
110
371
7.56
33.94
5.6
4.6
0.0
0.0
estimate
0.00
16
133
58
128
6.60
27.23
1.4
2.2
0.2
0.2
g/l
2.60
58
121
53
120
6.16
23.94
2.1
2.9
62.3
61.2
ml/min/173m2
0.08
26
45
43
85
6.59
22.22
5.7
7.9
24.6
25.7
mmol/l
1.37
43
79
39
70
7.08
22.13
3.2
7.7
95.0
94.8
%
0.18
39
70
113
536
4.95
19.63
5.9
4.4
—
—
—
0
0
44
123
4.58
14.98
3.1
6.9
123.7
119.4
g/l
0.67
44
118
124
708
4.57
14.97
5.8
4.2
0.0
0.0
estimate
0.50
16
126
122
698
4.35
14.45
5.9
4.1
0.0
0.0
estimate
0.00
16
131
121
704
4.13
13.61
6.4
5.6
0.0
0.0
estimate
0.00
13
127
46
149
3.95
12.69
3.2
6.4
13.3
12.5
kpa
0.41
46
143
46
149
3.95
12.69
3.2
6.4
5.2
5.3
kpa
0.11
46
143
116
679
3.71
12.41
4.5
3.7
—
—
—
0
0
46
153
3.84
12.17
3.1
6.3
1.3
1.8
mmol/l
0.77
34
128
106
623
3.16
10.53
3.4
3.7
37.1
35.5
g/l
3.10
98
578
44
158
3.48
10.23
3.5
5.5
104.2
103.4
mmol/l
0.61
44
151
61
307
2.61
7.49
1.4
1.4
—
—
—
0
0
19
50
4.19
6.76
1.5
1.4
—
—
—
0
0
76
488
2.08
4.82
3.0
2.9
—
—
—
0
0
87
1131
0.48
4.70
10.2
17.4
14.3
13.7
%
2.10
82
1111
76
520
1.89
3.76
4.8
3.5
18.5
32.4
ng/l
0.83
55
365
22
407
0.47
2.86
1.5
1.6
1.6
1.3
mmol/l
0.51
17
335
131
1122
2.01
2.73
5.5
4.4
15.4
14.9
pmol/l
1.65
122
1017
86
663
1.66
2.48
3.5
4.8
1.2
1.2
mmol/l
6.52
77
592
20
98
2.19
2.44
1.3
1.6
—
—
—
0
0
5
9
5.69
2.23
2.8
3.9
—
—
—
0
0
9
31
3.02
2.11
1.8
1.2
—
—
—
0
0
13
57
2.40
2.04
1.8
3.6
48.9
46.2
%
0.12
13
57
97
801
1.55
1.89
4.0
4.2
6.8
6.6
mmol/l
0.52
92
744
0
47
0.00
1.74
0.0
1.9
—
—
—
0
0
146
1349
2.17
1.73
15.8
13.9
26.3
21.4
mg/l
0.66
123
1048
0
49
0.00
1.72
0.0
1.9
—
—
—
0
0
30
437
0.61
1.61
2.1
2.9
28.6
28.4
u/l
0.03
25
418
20
322
0.57
1.58
1.3
1.2
0.7
1.5
u/ml
—
9
87
46
338
1.51
1.48
1.9
1.9
—
—
—
0
0
96
817
1.45
1.44
6.6
8.9
4.1
4.0
e9/l
0.16
89
717
9
40
2.32
1.42
2.0
1.3
—
—
—
0
0
150
1424
2.20
1.41
18.0
16.4
71.2
69.8
umol/l
0.29
150
1424
0
38
0.00
1.36
0.0
3.5
—
24.2
—
0
31
0
39
0.00
1.36
0.0
1.6
—
—
—
0
0
138
1273
1.69
1.34
4.6
4.1
1.4
1.2
mmol/l
1.37
125
1148
72
856
0.71
1.33
2.4
2.9
50.0
44.8
u/l
0.20
65
784
144
1346
1.84
1.30
5.4
4.7
6.2
5.9
mmol/l
2.85
136
1234
86
727
1.40
1.28
3.8
5.6
1.2
1.2
mmol/l
6.36
74
614
139
1288
1.69
1.28
6.6
5.8
41.1
39.6
mmol/mol
1.03
130
1187
146
1376
1.87
1.19
5.7
5.2
2.9
2.8
mmol/l
0.32
134
1258
8
41
2.00
1.10
2.9
2.9
—
—
—
0
0
41
315
1.41
1.03
1.5
1.6
0.7
1.0
mg/l
1.08
31
241
52
631
0.74
1.00
2.2
2.3
78.2
80.4
nmol/l
0.25
47
551
0
31
0.00
0.97
0.0
1.3
—
—
—
0
0
11
62
1.83
0.97
1.5
1.3
—
—
—
0
0
11
62
1.83
0.97
1.6
2.3
1.3
1.1
%
0.41
11
62
9
51
1.81
0.96
1.7
1.3
—
—
—
0
0
7
126
0.53
0.93
3.9
3.5
—
—
—
0
0
142
1348
1.56
0.85
5.1
4.6
4.8
4.8
mmol/l
0.24
131
1235
138
1305
1.47
0.81
6.4
5.4
2.7
1.9
mu/l
0.85
129
1189
0
24
0.00
0.80
0.0
1.3
—
—
—
0
0
0
24
0.00
0.80
0.0
1.3
—
—
—
0
0
0
24
0.00
0.80
0.0
1.3
—
—
—
0
0
0
25
0.00
0.80
0.0
1.7
—
—
—
0
0
0
26
0.00
0.79
0.0
1.1
—
—
—
0
0
53
624
0.77
0.78
1.9
2.0
95.2
100.5
pmol/l
0.48
37
274
117
1081
1.32
0.77
5.3
7.2
80.2
78.0
u/l
0.18
111
992
6
34
1.79
0.77
2.3
2.2
—
—
—
0
0
9
57
1.61
0.72
1.3
1.2
—
—
—
0
0
9
58
1.58
0.71
1.3
1.2
—
—
—
0
0
68
764
0.81
0.63
2.4
2.7
—
—
—
0
0
10
63
1.63
0.63
1.6
3.2
24.9
25.7
mmol/l
—
10
63
0
20
0.00
0.61
0.0
2.1
—
15.1
—
0
6
18
132
1.41
0.60
3.0
4.6
231.0
301.5
u/l
0.58
18
122
0
23
0.00
0.59
0.0
1.4
—
—
—
0
0
139
1333
1.37
0.57
4.9
4.6
1.5
1.6
mmol/l
2.28
127
1215
12
82
1.50
0.56
1.9
1.3
—
—
—
0
0
24
190
1.31
0.52
1.4
1.6
26.8
29.0
s
1.62
24
182
19
146
1.34
0.50
1.6
1.8
—
—
—
0
0
37
313
1.24
0.48
2.1
2.4
326.1
10017.1
umol/l
2.51
31
265
5
31
1.63
0.43
1.2
1.6
—
—
—
0
0
5
33
1.53
0.41
1.8
1.6
—
—
—
0
0
5
33
1.53
0.41
1.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
2.9
—
0
9
0
17
0.00
0.41
0.0
4.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
8
113
0.69
0.38
1.5
1.2
1.5
1.3
%
—
8
100
6
90
0.65
0.33
1.2
1.7
—
—
—
0
0
38
336
1.17
0.32
2.3
2.1
4.9
3.3
mg/l
1.70
33
282
33
289
1.18
0.31
1.5
1.6
477.2
480.0
pmol/l
0.02
26
233
31
273
1.17
0.28
1.2
1.3
12.3
11.1
u/ml
0.04
21
101
5
71
0.69
0.26
1.0
1.0
—
—
—
0
0
6
83
0.71
0.24
1.2
1.6
—
—
—
0
0
58
539
1.12
0.24
2.9
3.2
2.4
2.4
mmol/l
0.45
52
459
7
93
0.74
0.23
1.6
1.5
—
—
—
0
0
17
145
1.19
0.21
1.3
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
2.5
—
13.5
—
0
11
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
60.3
—
0
6
0
13
0.00
0.21
0.0
1.1
—
29.1
—
0
8
0
13
0.00
0.21
0.0
1.0
—
643.1
—
0
8
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
62
585
1.10
0.19
2.2
2.6
114.9
90.8
ug/l
0.57
57
534
108
1046
1.10
0.19
4.5
4.4
15.6
13.0
mm/h
0.96
99
949
13
110
1.20
0.18
1.8
5.1
1.2
1.4
mmol/l
0.57
13
105
5
66
0.75
0.17
2.6
5.4
24.6
25.8
mmol/l
—
5
66
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
19
204
0.92
0.07
1.6
1.8
—
—
—
0
0
127
1283
0.95
0.05
7.9
13.1
75.9
77.4
ml/min/173m2
0.32
108
1046
12
126
0.95
0.00
2.3
2.0
402.7
373.5
nmol/l
0.48
12
119
27
275
0.98
0.00
1.3
1.3
34.3
41.9
iu/ml
—
9
90
21
215
0.97
0.00
1.7
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
0.3
—
0
5
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
2.2
—
105.9
—
0
9
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
2.4
—
77.5
—
0
5
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
9.9
—
0
7
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_ENDOMETRIUM – Carcinoma in situ of endometrium
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).